The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...

The Biden administration is proposing changes to Medicare Advantage plans designed to alleviate coverage barriers ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Sarepta Therapeutics said Tuesday that it will pay Arrowhead Pharmaceuticals $500 million in cash for a series of ...

An Amgen obesity drug helped participants lose a substantial amount of weight, but questions about how competitive it could ...

A cancer treatment from Roche failed to improve survival in a major lung cancer study, a result that will stoke doubts about ...

Will the Novo-Catalent merger be challenged under the new Trump administration? A former FTC policy director thinks so.

What’s more, the rise of technology in medicine, while beneficial in many ways, has further reduced the use of empathic touch ...

The new class of GLP-1 weight loss drugs have been blockbusters since they arrived on the market a few years ago. These ...

The Biden administration is proposing a major expansion of how Medicare and Medicaid cover Wegovy and Zepbound ...

Late Friday evening, President-elect Donald Trump announced a slew of intended nominations for his administration, including ...

Alector Therapeutics, working with AbbVie, was testing whether modulating immune cells in brain would slow Alzheimer's ...